The newly developed Mechanochemical Endovenous Ablation (MOCA) device uses a technique that combines mechanical endothelial damage using a rotating wire with the infusion of a liquid sclerosant. Heating of the vein and tumescent anesthesia are not required; only local anesthesia is utilized at the insertion site. Previously we showed that endovenous MOCA, using polidocanol, is feasible and safe in the treatment of great spahenous vein (GSV) incompetence. However, larger studies with a prolonged follow-up to prove the efficacy of this technique in terms of obliteration rates are lacking. This randomized trial was designed to compare occlusion rate, post-operative pain and complications between radiofrequency ablation (RFA: the current treatment for GSV incompetence) en MOCA.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
213
Mechanochemical Endovenous Ablation (MOCA)for treatment of great saphenous vein incompetence
Radiofrequency ablation (RFA)for treatment of great saphenous vein incompetence
Rijnstate Hospital
Arnhem, Gelderland, Netherlands
BovenIJ Hospital
Amsterdam, Netherlands
OLVG
Amsterdam, Netherlands
UMCG
Groningen, Netherlands
St. Antonius Hospital
Nieuwegein, Netherlands
Occlusion rate
Occlusion rates between treatments will be compared at mentioned time points (both technical and clinical success)
Time frame: up to 5 years
Per-procedural pain score
Pain during the procedure will be compared between treatments using the VAS score
Time frame: two weeks
Complications
Complication at day 30 will be compared between treatments.
Time frame: 30 days
Procedure duration
The duration of the procedures will be compared
Time frame: 30 days
Costs of both treatments
The total costs of both treatments will be compared
Time frame: 1 year
Health status
Using the RAND 36-Item short From Health Survey (SF36) the general health status will be compared between treatments at various time points as specified by the protocol.
Time frame: 1 year, 5 years
Post procedural pain score
Pain during the the first two weeks after the procedure will be compared between treatments using the VAS score
Time frame: two weeks
Disease related quality of life
Using the Aberdeen Varicose Vein Questionnaire (AVVQ)the disease related quality of life will be compared between treatments at various time points as specified by the protocol.
Time frame: 1 year, 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.